KRMD Repro Med Systems Inc
REPRO MED SYSTEMS INC. d/b/a KORU Medical Systems (“KORU Medical,” “KORU”, the “Company” “our” or “we”), designs, manufactures and markets proprietary and innovative portable medical devices, primarily for the ambulatory infusion market in compliance with the United States Food and Drug Administration (the “FDA”) quality and regulatory system and international standards for quality system management. Our development and marketing focus is primarily concentrated on our mechanical infusion products, the FREEDOM Infusion Systems (which we refer to as the “FREEDOM System” when used with one or more accessories), which include the FREEDOM60® Syringe Driver, the FreedomEdge® Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets™ and Precision Flow Rate Tubing™. The Company incorporated in the State of New York in March 1980.
Company profile
Ticker
KRMD
Exchange
Website
CEO
Donald B. Pettigrew
Employees
Incorporated in
Location
Fiscal year end
Sector
Industry (SEC)
3M • Boston Scientific • Baxter International • Stryker • Becton Dickinson & Co • Teleflex • ResMed • Hill-Rom • Integra Lifesciences • AngioDynamics ...
SEC CIK
Corporate docs
IRS number
133044880
KRMD stock data
()
Calendar
6 May 20
8 Jul 20
31 Dec 20
News
Company financial data Financial data
| Quarter (USD) | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|
| Revenue | 6.33M | 6.22M | 6.62M | 5.35M | |
| Net income | 449.43K | -80.26K | 651.81K | 78.18K | |
| Diluted EPS | 0.01 | -0.01 | 0.02 | 0 | |
| Net profit margin | 7.10% | -1.29% | 9.85% | 1.46% | |
| Operating income | 582.82K | -159.64K | 824.48K | 35.88K | |
| Net change in cash | 1.56M | 741.9K | 1.32M | 1.21M | |
| Cash on hand | 7.43M | 5.87M | 5.13M | 3.81M | |
| Cost of revenue | 2.54M | 2.27M | 2.23M | 1.87M |
| Annual (USD) | Dec 19 | Dec 18 |
|---|---|---|
| Revenue | 23.16M | 17.35M |
| Net income | 564.35K | 910.57K |
| Diluted EPS | 0.01 | 0.02 |
| Net profit margin | 2.44% | 5.25% |
| Operating income | 585.68K | 1.16M |
| Net change in cash | 2.13M | |
| Cash on hand | 5.87M | 3.74M |
| Cost of revenue | 8.31M | 6.54M |
Financial data from company earnings reports
Recent insider trades
| Date | Owner | Security | Transaction | Code | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|
| 30 Jun 20 | Goldberger Daniel S | Common Stock | Grant | Aquire A | No | 8.98 | 696 | 6.25K | 97,408 |
| 30 Jun 20 | Anderson David W | Common Stock | Grant | Aquire A | No | 8.98 | 835 | 7.5K | 36,939 |
| 30 Jun 20 | Beck James M | Common Stock | Grant | Aquire A | No | 8.98 | 835 | 7.5K | 47,297 |
| 30 Jun 20 | Frommer Kathy | Common Stock | Grant | Aquire A | No | 8.98 | 696 | 6.25K | 705,713 |
| 30 Jun 20 | Fletcher R John | Common Stock | Grant | Aquire A | No | 8.98 | 2,088 | 18.75K | 26,401 |
Institutional ownership Q1 2020
60.3% owned by funds/institutions
13F holders |
Current |
|---|---|
| Total holders | 57 |
| Opened positions | 23 |
| Closed positions | 7 |
| Increased positions | 19 |
| Reduced positions | 7 |
13F shares |
Current |
|---|---|
| Total value | 1.14B |
| Total shares | 24.32M |
| Total puts | 0 |
| Total calls | 0 |
| Total put/call ratio | – |
Largest owners |
Shares | Value |
|---|---|---|
| Horton Capital Management | 12.18M | $91.32M |
| First Light Asset Management | 7.24M | $54.29M |
| Vanguard | 1.06M | $7.98M |
| Parkman Healthcare Partners | 571.99K | $4.29M |
| EAM Investors | 347.82K | $2.61M |
| Millennium Management | 265.16K | $1.99M |
| Susquehanna International | 215.78K | $1.62M |
| Friess Associates | 208.31K | $1.56M |
| WASHINGTON TRUST | 201K | $1.51M |
| EAM Global Investors | 192.99K | $1.45M |
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
accrual, administered, Aid, anniversary, annum, apparent, appendix, argument, avoid, Bank, bear, built, CAFC, calendar, chain, clarifying, cleaning, confer, converted, creating, customary, default, directly, disbursement, discontinuation, discontinued, disrupting, distancing, distribution, division, drawn, drew, duration, earlier, economic, eighteen, eligible, essential, evolve, experience, failure, forgiven, geographic, global, governmental, heightened, immune, infection, installment, instituted, institutional, joint, judicial, KEF, kind, largest, likelihood, located, Manuel, Master, met, methodology, monitor, monitoring, MSA, negative, obsolescence, oral, outbreak, overtime, pandemic, panel, party, Paycheck, penalty, person, plasma, policy, potential, PPLSA, PPP, prepaid, prepayment, Prime, Protection, pursue, qualify, qualifying, reduce, remotely, reply, reserve, resolution, respiratory, reversing, safeguard, safety, sanitization, show, simplify, Simplifying, situation, social, spread, staffing, sunset, supply, sustaining, therapy, travel, treatment, type, unknown, unpaid, utilizing, vital, vulnerable, waiting, wholly, work, workforce, world, worldwide, worsening
Removed:
addition, Additionally, aircraft, AMI, applied, arrangement, attrition, Aviation, capitalizing, ceased, Cloud, Computing, contract, delay, description, develop, element, establish, event, Framework, Goodwill, history, hosting, intangible, investor, leasing, lending, Level, license, lived, long, modified, modify, narrative, obtain, permitted, prospectively, range, relation, removed, retrospectively, shareholder, software, Subtopic, tangible, unobservable, unpredictability, unrealized, Vice
Financial reports
10-Q
2020 Q1
Quarterly report
6 May 20
10-K
2019 FY
Annual report
4 Mar 20
10-Q
2019 Q3
Quarterly report
6 Nov 19
10-Q
2019 Q2
Quarterly report
7 Aug 19
10-Q
2019 Q1
Quarterly report
7 May 19
10-K
2018 FY
Annual report
5 Mar 19
10-Q
2018 Q3
Quarterly report
9 Nov 18
10-Q
2018 Q2
Quarterly report
6 Aug 18
10-Q
2018 Q1
Quarterly report
7 May 18
10-KT
2017 FY
Filing
5 Mar 18
Current reports
8-K
KORU Medical Commences Public Offering of Common Stock
22 Jun 20
8-K
Other Events
18 Jun 20
8-K
Koru Medical Systems and Emed Technologies Corporation Announce Settlement of All Pending Litigation
26 May 20
8-K
Other Events
14 May 20
8-K
Koru Medical Systems Announces 2020 First Quarter Financial Results
5 May 20
8-K
Entry into a Material Definitive Agreement
30 Apr 20
8-K
Submission of Matters to a Vote of Security Holders
24 Apr 20
8-K
United States Federal Court of Appeals Rules In Favor of Koru Medical Systems
14 Apr 20
8-K
KORU Medical Systems Announces Record 2019 Fourth Quarter and Full Year Financial Results
25 Feb 20
8-K
Departure of Directors or Certain Officers
24 Jan 20
Registration and prospectus
424B5
Prospectus supplement for primary offering
22 Jun 20
424B5
Prospectus supplement for primary offering
18 Jun 20
S-3
Shelf registration
14 May 20
424B3
Prospectus supplement
12 Mar 20
POS AM
Prospectus update (post-effective amendment)
4 Mar 20
424B3
Prospectus supplement
25 Feb 20
424B3
Prospectus supplement
24 Jan 20
424B3
Prospectus supplement
14 Nov 19
424B3
Prospectus supplement
6 Nov 19
424B3
Prospectus supplement
5 Nov 19
Proxies
DEFA14A
Additional proxy soliciting materials
31 Mar 20
DEF 14A
Definitive proxy
6 Mar 20
DEFA14A
Additional proxy soliciting materials
29 Mar 19
DEF 14A
Definitive proxy
8 Mar 19
PRE 14A
Preliminary proxy
21 Feb 19
DEF 14A
Definitive proxy
13 Mar 18
DEFA14A
Additional proxy soliciting materials
17 Aug 16
DEF 14A
Definitive proxy
28 Jul 16
PRE 14A
Preliminary proxy
8 Jul 16
Other
EFFECT
Notice of effectiveness
21 May 20
CORRESP
Correspondence with SEC
18 May 20
UPLOAD
Letter from SEC
18 May 20
EFFECT
Notice of effectiveness
12 Mar 20
EFFECT
Notice of effectiveness
11 Mar 19
UPLOAD
Letter from SEC
11 Mar 11
CORRESP
Correspondence with SEC
2 Mar 11
UPLOAD
Letter from SEC
23 Feb 11
UPLOAD
Letter from SEC
6 Jan 09
UPLOAD
Letter from SEC
11 Dec 08
Ownership
4
REPRO MED SYSTEMS / Joseph M. Jr. Manko ownership change
2 Jul 20
4
REPRO MED SYSTEMS / Robert T Allen ownership change
2 Jul 20
4
REPRO MED SYSTEMS / Kathy Frommer ownership change
2 Jul 20
4
REPRO MED SYSTEMS / R JOHN FLETCHER ownership change
2 Jul 20
4
REPRO MED SYSTEMS / James M Beck ownership change
2 Jul 20
4
REPRO MED SYSTEMS / David W Anderson ownership change
2 Jul 20
4
REPRO MED SYSTEMS / Daniel S Goldberger ownership change
2 Jul 20
4
REPRO MED SYSTEMS / Karen Fisher ownership change
11 May 20
3/A
REPRO MED SYSTEMS / Kathy Frommer ownership change
7 May 20
4
REPRO MED SYSTEMS / Joseph M. Jr. Manko ownership change
1 Apr 20